Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2012
12/06/2012US20120308633 Nanostructured material formulated with bone cement for effective antibiotic delivery
12/06/2012US20120308629 Injectable bulking compositions
12/06/2012US20120308627 Liquid-filled protein-phosphatidic acid capsule dispersions
12/06/2012US20120308625 A method for altering the flavor of a food product
12/06/2012US20120308623 Composition comprising nanoparticles of ti02
12/06/2012US20120308622 Compositions of Apatite and Methods of Use
12/06/2012US20120308618 Ic31 nanoparticles
12/06/2012US20120308617 Phospholipid-based inhalation system
12/06/2012US20120308616 Submicro emulsion of paclitaxel using steroid complex as intermediate carrier
12/06/2012US20120308615 Formulation of hepatitis b virus antigens for cellular stimulation followed by therapeutic immunization
12/06/2012US20120308614 Composition for the controlled release of buprenorphine
12/06/2012US20120308613 Formulations for use in inhaler devices
12/06/2012US20120308612 Compositions and methods for preparation of poorly water soluble drugs with increased stability
12/06/2012US20120308611 Fibrous protein fusions and use thereof in the formation of advanced organic/inorganic composite materials
12/06/2012US20120308610 Materials and Methods for Altering an Immune Response to Exogenous and Endogenous Immunogens, Including Syngeneic and Non-Syngeneic Cells, Tissues or Organs
12/06/2012US20120308492 Foamable oil-water emulsion
12/06/2012US20120308483 Treatment of Sleep Disturbances
12/06/2012US20120305174 Layer processing for pharmaceuticals
12/06/2012CA2843470A1 Brain tumor targeting peptides and methods
12/06/2012CA2838179A1 Targeted delivery of retinoid compounds to the sebaceous glands
12/06/2012CA2838059A1 Method, composition, and articles for improving joint lubrication
12/06/2012CA2837753A1 Polysaccharide-based hydrogel polymer and uses thereof
12/06/2012CA2837266A1 Amorphous ritonavir co-precipitated
12/06/2012CA2837241A1 Composition and tablet comprising raltegravir
12/06/2012CA2837240A1 Ophthalmic preparation comprising a pgf2.alpha. analogue
12/06/2012CA2837176A1 Stable liquid formulation of etanercept
12/06/2012CA2837077A1 Controlled release solid dose forms
12/06/2012CA2836904A1 Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current
12/06/2012CA2836511A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
12/06/2012CA2836025A1 Nasal pharmaceutical formulation comprising fluticasone
12/06/2012CA2835858A1 Compositions for preventing cardiac arrhythmia
12/05/2012EP2529757A1 Paliperidone implant formulation
12/05/2012EP2529755A1 Pharmaceutical composition and preparation for oral administration
12/05/2012EP2529741A1 Composition and Tablet Comprising Raltegravir
12/05/2012EP2529732A1 Transdermal therapeutic system with an adhesive layer, method for siliconizing a backing layer of the system and use the use of the backing layer
12/05/2012EP2529731A1 Particulate preparation and method for producing the same
12/05/2012EP2529730A1 Oral sustained-release composition
12/05/2012EP2529729A1 Balsalazide formulations and manufacture thereof
12/05/2012EP2529728A1 Pharmaceutical compositions for the treatment of bacterial infections
12/05/2012EP2529004A2 Dry glassy composition comprising a bioactive material
12/05/2012EP2528617A1 Cytokines for the treatment of addictions
12/05/2012EP2528609A1 Propolis and process for the treatment thereof and end products formed therefrom.
12/05/2012EP2528602A1 Formulations of bendamustine
12/05/2012EP2528601A1 Compositions and methods for prevention and treatment of pulmonary hypertension
12/05/2012EP2528600A1 Dry powder pharmaceutical composition comprising tiotropium and fluticasone
12/05/2012EP2528597A1 Dry powder formulation comprising a pharmaceutical combination of tiotropium bromide, formoterol fumarate and mometasone furoate
12/05/2012EP2528596A1 Dry powder formulations administered by the inhalation route comprising a combination of tiotropium bromide, salmeterol xynafoate and fluticasone propionate.
12/05/2012EP2528594A2 Effervescent formulations comprising second generation cephalosporin
12/05/2012EP2528593A2 Effervescent formulations comprising cefprozil as active agent
12/05/2012EP2528592A2 Moire patterns generated by angular illumination of surfaces
12/05/2012EP2528591A2 Effervescent formulations comprising cefaclor
12/05/2012EP2528590A2 Effervescent dosage forms comprising cephalosporin antibiotic
12/05/2012EP2528589A2 Stable efervescent formulations comprising cefaclor
12/05/2012EP2528587A1 Methods for internally controlling or treating equine bot larvae
12/05/2012EP2528586A1 Effervescent formulations comprising cefixime and clavulanic acid as active agents
12/05/2012EP2528585A1 Pharmaceutical compositions comprising tiotropium, formoterol and budesonide
12/05/2012EP2528584A1 Water dispersible cefdinir and clavulanic acid formulations for treatment of bacterial infections
12/05/2012EP2528536A1 Dental strip for administration of oral treatment
12/05/2012EP2079456B1 Pharmaceutical cyclosporin compositions
12/05/2012CN202568935U Medicinal fungus lozenge structure for inhibiting tumor
12/05/2012CN202568934U Tablet capsule filled with glipizide solid preparations and metformin solid preparations
12/05/2012CN202568933U Novel amlodipine and benazepril capsule
12/05/2012CN202568932U Novel capsule containing irbesartan solid preparation and hydrochlorothiazide solid preparation
12/05/2012CN202568931U Novel compound capsule containing ferrous fumarate and folic acid
12/05/2012CN202568930U Tablet capsule with repaglinide solid preparation and dimethyldiguanide solid preparation
12/05/2012CN202568929U Tablet capsules containing rosiglitazone solid preparation and metformin solid preparation
12/05/2012CN202568928U Tablet capsule filled with valsartan tablet and amlodipine tablet
12/05/2012CN202568927U Novel capsule containing Roflumilast solid preparation and Formoterol solid preparation
12/05/2012CN202568926U Tablet capsule filled with alogliptin solid preparation and pioglitazone solid preparation
12/05/2012CN202568925U Tablet capsule filled with valsartan solid preparation and hydrochlorothiazide solid preparation
12/05/2012CN202568924U Tablet capsule with losartan tablet and hydrochlorothiazide tablet
12/05/2012CN202568923U Sealing capsule for medicines
12/05/2012CN202568893U System for preparing multi-vitamin
12/05/2012CN102812015A Antiprotozoal compound originating in coelenterata
12/05/2012CN102811763A Proteoglycan-containing microneedle array
12/05/2012CN102811747A Solid composition for the oral administration of dyes and diagnostic use thereof
12/05/2012CN102811746A Methods and compositions for nanoparticle-mediated cancer cell-targeted delivery
12/05/2012CN102811745A Liposomes containing prostaglandin e1 (pge1), formulations containing them and their use
12/05/2012CN102811741A Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation
12/05/2012CN102811737A Pharmaceutical composition for treatment or prevention of osteoarthritis, and method of production therefor
12/05/2012CN102811724A Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing same
12/05/2012CN102811720A Use of iminocyclitols as inhibitors of bacterial adherence to epithelial cells
12/05/2012CN102811717A Nutritional composition
12/05/2012CN102811712A Solid preparation
12/05/2012CN102811711A Solid preparation
12/05/2012CN102811710A Rapid-release encapsulation composition
12/05/2012CN102811709A Process And Product
12/05/2012CN102811708A Vesicle-containing composition
12/05/2012CN102811707A Biomineral and metal binding liposomes, their synthesis, and methods of use thereof
12/05/2012CN102811705A Implant Devices Having Varying Bioactive Agent Loading Configurations
12/05/2012CN102811697A Clear or Translucent Composition
12/05/2012CN102807657A Amphiphilic waterborne segmented copolymer medicament carrier with pH responsiveness and biodegradability and preparation thereof
12/05/2012CN102805896A Transdermal administration method, preparation and system
12/05/2012CN102805873A Gene drug co-carrier system using cation liposome to establish gold nano-spherical shell and preparation method
12/05/2012CN102805871A Material of soybean polysaccharide hollow capsule and production method of capsule
12/05/2012CN102805865A Eye drop administration device system and preparation
12/05/2012CN102805858A High-efficiency calcium supplement capsule and preparation method thereof
12/05/2012CN102805857A Preparation method of compound amino acid (15) dipeptide (2) injecta
12/05/2012CN102805855A Hydrophilic cataplasm for preventing and curing motion sickness
12/05/2012CN102805837A Traditional Chinese medicine granules for treating dysmenorrheal and preparation method thereof
1 ... 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 ... 2991